Epigenetic Editing Reverses Cellular Aging in Landmark Human Trial
A Columbia/Alkahest collaboration using CRISPRoff epigenetic editing reversed cellular aging markers in older adults. Here's what the Nature Medicine trial shows — and what it means for healthy longevity.
Dr. Amrita S. Pai, PharmD Sep 14, 2026 3 min read